Lipid Signaling Molecule Regulates Immune Responses in Mice
News
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1527021795674-5'); });
Lipid (fat) molecules can function as chemical ... Read more
Safety Board Says Phase 2 Temelimab Trial Should Move Forward
News
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1527021795674-5'); });
A Phase 2a clinical trial evaluating GeNeuro‘s ... Read more
Rising Temperatures Could Lead to Greater Care Needs for MS Patients
News
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1527021795674-5'); });
Rising average temperatures may lead to a ... Read more
#ACTRIMS2021 – Taking Medication During Pregnancy Reduces Healthcare Costs
ACTRIMS 2021, News
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1527021795674-5'); });
Editor’s note: The Multiple Sclerosis News Today news ... Read more
It’s March – Make Time for MS Awareness
News
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1527021795674-5'); });
Note: This story was updated March 8, ... Read more
Antigen-loaded Red Blood Cells Help Promote Immune Tolerance in Mice
News
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1527021795674-5'); });
Red blood cells carrying specific antigen proteins ... Read more
BMS Grants to National MS Society, Others Aim for Diversity in Care and Trials
News
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1527021795674-5'); });
The National Multiple Sclerosis Society was among 56 ... Read more
#ACTRIMS2021 – Benign Versus Aggressive MS – the Hunt for Clues
ACTRIMS 2021, News
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1527021795674-5'); });
Editor’s note: The Multiple Sclerosis News Today news ... Read more
#ACTRIMS2021 – Cognitive, Without Physical, Disability Growing Concern in MS
ACTRIMS 2021, News
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1527021795674-5'); });
Editor’s note: The Multiple Sclerosis News Today news ... Read more
#ACTRIMS2021 – Reduced Methionine in Diet Eased Symptoms in MS Mice
ACTRIMS 2021, News
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1527021795674-5'); });
Editor’s note: The Multiple Sclerosis News Today news ... Read more
NMSS Partnership Targets Autoimmune Disease Research
News
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1527021795674-5'); });
The National Multiple Sclerosis Society has joined ... Read more
#ACTRIMS2021 – Dietary Restriction May Limit Severity of MS
ACTRIMS 2021, News
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1527021795674-5'); });
Editor’s note: The Multiple Sclerosis News Today news ... Read more
#ACTRIMS2021 – Research Finds Race- and Ethnicity-based Differences in MS Therapies
ACTRIMS 2021, News
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1527021795674-5'); });
Editor’s note: The Multiple Sclerosis News Today news ... Read more
#ACTRIMS2021 – COVID-19 Vaccines Safe for MS Patients, Minimally Affected by DMTs
ACTRIMS 2021, News
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1527021795674-5'); });
Editor’s note: The Multiple Sclerosis News Today news ... Read more
#ACTRIMS2021 -MS Demographics in Latin America Broadly Similar to US, Europe
ACTRIMS 2021, News
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1527021795674-5'); });
Editor’s note: The Multiple Sclerosis News Today news ... Read more
#ACTRIMS2021 – Leptin’s Pro-inflammatory Effects May Link Obesity to MS
ACTRIMS 2021, News
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1527021795674-5'); });
Editor’s note: The Multiple Sclerosis News Today news ... Read more
#ACTRIMS2021 – Realities and Challenges of MS in Latin America
ACTRIMS 2021, News
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1527021795674-5'); });
Editor’s note: The Multiple Sclerosis News Today news ... Read more
Imcyse Raises €21.3M to Advance Treatments for MS, Other Diseases
News
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1527021795674-5'); });
Imcyse has raised €21.3 million ($25.8 million) ... Read more
